EurekAlert (press release)Gene therapy for pompe disease effective in mice, poised for human trialsEurekAlert (press release)The Duke-led research team found that a single small dose of gene therapy was as effective as enzyme replacement therapy (ERT) … Continue reading
|
Cellecta Awarded Phase II SBIR Grant to Finalize Development of CRISPR Screening Platform
GenomeWeb NEW YORK (GenomeWeb) – Cellecta announced today that it has been awarded a Phase II SBIR grant from the National Institutes of Health to complete development of a genome-wide CRISPR/Cas9 screening platform that it aims to commercialize by late … Cellecta, Inc. Receives Phase II NIH SBIR Grant to Develop Advanced CRISPR/Cas9 Genome-Wide sgRNA Library …Military Technologies |
Immuno-Oncology News |
Platelets Can Deliver Immunotherapies Directly to Cancer Cells, Preventing Harm Elsewhere, Study Shows
Immuno-Oncology News Immunotherapy has shown promise in eliminating the microtumors that sometimes remain after cancer surgery, but the treatment’s effects on other parts of the body have raised concern. Platelets could be the answer, researchers have discovered. The tiny … |
Immuno-Oncology News |
Platelets Can Deliver Immunotherapies Directly to Cancer Cells, Preventing Harm Elsewhere, Study Shows
Immuno-Oncology News Immunotherapy has shown promise in eliminating the microtumors that sometimes remain after cancer surgery, but the treatment’s effects on other parts of the body have raised concern. Platelets could be the answer, researchers have discovered. The tiny … |